Innovations
For Abyss, collaborations are essential. They allow us to pool knowledge and expertise, as well as resources (financial and human), with the aim of fostering innovation.
​
Since 2016, we have engaged in collaborative projects with multiple partners to further develop the science behind our existing products and explore new validated active ingredients.
Alg4Health (2023 – 2027)
Objective : To develop a new bioactive ingredient and functional foods from a byproduct obtained through an eco-responsible transformation process of marine algae, and scientifically and clinically validate their benefits on the cognitive health of seniors and athletes.
​
Biotech Santé Bretagne and Valorial are involved in this project as facilitators. Alg4Health has also received co-labeling from the Valorial and Agri Sud-Ouest Innovation Innovation clusters.
​
This collaborative project, with a total budget of 3.7 million euros, is supported and funded by BPI France as part of France 2030.
BrainBooster (2016 – 2021)
Objective : To develop an innovative marine active ingredient that is scientifically and clinically validated to prevent age-related cognitive decline, especially in humans.
​
Biotech Santé Bretagne and Valorial are involved in this project as facilitators. BrainBooster has also received co-labeling from Valorial and the Pôle Mer Bretagne Atlantique.
​
This collaborative project, with a total budget of 2.5 million euros, has been supported and partially financed by institutional financial partners including BPI France, the Brittany Region, and local authorities such as Lorient agglomération and the Finistère department.
​
Result: Launch of our Mnemosyss® in October 2021.
VIPP (2019 – 2022)
Objective: To identify and characterize the bioactive peptides responsible for stress management in Peptidyss®.
​
The VIPP project has been certified by the Valorial and Pôle Mer Bretagne Atlantique clusters, with the support of Biotech Santé Bretagne and the Technopole Quimper-Cornouaille.
​
This collaborative project, with a total amount of €900k, was supported and partially financed by institutional financial partners such as Feder, the Brittany Region, and the local authorities, Lorient agglomération, and Saint-Malo agglomération.
Result: Improved understanding of Peptidyss and reinforcement of its mechanisms of action through a proteomic approach.
eCabyss (2019-2021)
Objective : To develop an innovative bioactive biomaterial from marine bioresources for bone reconstruction.
​
Biotech Santé Bretagne is involved in this project as a guiding partner.
​
This collaborative project, with a total amount of €115k, was supported and partially financed by the institutional financial partner, the Brittany Region.
